The phenotypic reversion caused by knockdown of PSMA1 may be associated with the blocked degradation and increased protein levels of MDH2, suggesting that UPS may also be involved in the regulatory aspects of metabolic function in glioma cells. The gene discussed is PSMA1; the disease is central nervous system cancer.